TrialBlood advances2025
Olutasidenib alone or combined with azacitidine in patients with mutant IDH1 myelodysplastic syndrome.
Jorge E Cortes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
TrialBlood advances2025
Jorge E Cortes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.